A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)

Update Il y a 4 ans
Reference: NCT01643863

Woman and Man

  • | Country :
  • Portugal
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This multi-center observational study will evaluate the use of RoActemra/Actemra (tocilizumab) in monotherapy in patients with rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment according to the licensed label will be followed for 6 months.


Inclusion criteria

  • Rheumatoid Arthritis

Links